| Price | 7.60p on 01-05-2026 at 18:50:10 |
|---|---|
| Change | -0.85p -9.71% |
| Buy | 7.70p |
| Sell | 7.50p |
| Last Trade: | Buy 719.00 at 7.90p |
| Day's Volume: | 10,989,724 |
| Last Close: | 7.90p |
| Open: | 8.85p |
| ISIN: | GB00BYV81293 |
| Day's Range | 7.90p - 7.90p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £84.41m |
| VWAP: | 7.674367p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 719 | 7.90p | Suspected BUY Trade |
16:35:28 - 01-May-26 |
| Buy* | 1,500 | 7.70p | SI Trade |
16:33:52 - 01-May-26 |
| Buy* | 20 | 7.70p | SI Trade |
16:33:52 - 01-May-26 |
| Buy* | 627 | 7.70p | SI Trade |
16:33:52 - 01-May-26 |
| Buy* | 150 | 7.70p | SI Trade |
16:33:52 - 01-May-26 |
| Buy* | 9,751 | 7.65p | Ordinary |
16:29:04 - 01-May-26 |
| Buy* | 16,157 | 7.65p | Ordinary |
16:28:44 - 01-May-26 |
| Unknown* | 100,000 | 7.60p | Ordinary |
16:18:14 - 01-May-26 |
| Unknown* | 26,006 | 7.60p | Ordinary |
16:18:02 - 01-May-26 |
| Unknown* | 32,803 | 7.60p | Ordinary |
16:16:06 - 01-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
